The latest headlines across every section, pulled from official and open-access sources.
This cross-sectional study examines questionnaire responses of US medical school graduates to assess the association of sexual and gender minority identity with where graduates would prefer to start their practice.
Apnimed will apply the IPO proceeds toward the regulatory process and launch plans of Oxnimbi, a once-nightly pill developed for obstructive sleep apnea. This drug is under FDA review with a February 2027 target date for a regulatory decision. The post Apnimed’s IPO Bags $192M for What Could Become the First Oral Sleep Apnea Drug appeared first on MedCity News .
Health tech companies made several major funding announcements in July. Here is a list of some of the biggest funding rounds. The post 4 Notable Health Tech Funding Announcements in July appeared first on MedCity News .
The future of value-based care will hinge on empowering providers, and specialists in particular, with the data and strategic partnerships to proactively manage patient health beyond traditional clinical settings. The post The Next Phase of Value-Based Care: Why Specialty-Led Models Will Define the Future of Healthcare appeared first on MedCity News .
Hope is a catalyst for scientific ambition. It encourages researchers, clinicians, investors, and innovators to pursue solutions where none currently exist. In oncology, many major breakthroughs begin with the belief that a better answer is possible. The post Hope Is Not a Soft Concept, It’s a Strategic Imperative in Cancer Innovation appeared first on MedCity News .
Ready to explore a new professional opportunity? Browse the list below of featured jobs and take the next step in your career!
KFF Health News journalists made the rounds on national or local media recently to discuss topical stories. Here’s a collection of their appearances.
The NHS will begin contacting half a million men from this week inviting them to join a major research programme to improve early detection and treatment of prostate cancer. Men who have had or are living with prostate cancer will receive letters and text messages explaining how they can register to take part in what […]
July has seen a slew of executive hires, exits and layoffs across the healthcare industry. For instance, Aledade, Providence and Whoop named new executives. There were also layoffs at organizations including Novartis, Adventist Health and Wellstar Health System. The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared first on MedCity News .
Grove AI’s technology uses voice agents to recruit eligible patients for clinical trials. Formed in 2024, the startup’s rapid growth led to its acquisition by Hippocratic AI earlier this year. The post Startup to Acquisition in 2 Years: Grove AI’s Journey to Transform Clinical Trials appeared first on MedCity News .
On July 31, 2026, the Food and Drug Administration approved lutetium Lu 177 vipivotide tetraxetan (Pluvicto, Novartis Pharmaceuticals Corporation) in combination with androgen receptor pathway inhibitor (ARPI) therapy for adults with prostate-specific membrane antigen (PSMA)-positive metastatic andr
Daffodil Health launched an AI-powered solution to help payers manage No Surprises Act disputes by automating claims review, negotiations and arbitration workflows. The post Daffodil Health Launches No Surprises Act Dispute Management Solution appeared first on MedCity News .
ARLINGTON, VA – JULY 31, 2026 – Lidl US is expanding its July 24, 2026 recall of Eridanous Shortbread Cookies to include all units with a foreign language ingredients and nutrition facts panel for the following products:
This half-day virtual workshop features FDA expert presentations and audience Q&A on bioequivalence (BE) approaches for topical and transdermal generic drug products.
New Study: 500,000 Americans with Diabetes Projected to Lose Medicaid Coverage by 2034 mcarmody Fri, 07/31/2026 - 17:57 Press release New Study: 500,000 Americans with Diabetes Projected to Lose Medicaid Coverage by 2034 ARLINGTON, Va. August 3, 2026 A new study released by the American Diabetes Association ® (ADA) today estimates that, absent policy change, nearly 500,000 Medicaid beneficiaries with diabetes will lose healthcare coverage by 2034. According to the research—commissioned by the ADA from Health Management Associates—coverage losses will disproportionately affect Americans who…
In this final episode of the Increasing Role of UACR in Cardiovascular Care series, Drs. Ankeet Bhatt and Brendan Neuen will break down why UACR screening is one of the most powerful yet underused tools for identifying early cardiovascular risk.
CEO Kevin Lobo said the company is working through a backlog of orders and grappling with a supply disruption related to Inari Medical.
Selection of Appropriate SPL Codes for Human Prescription Drug Labeling (for SPL Drug Developers)
SBIA Conference/Workshop: Electronic Drug Registration and Listing (eDRLS) Using CDER Direct - 2023
Electronic Drug Registration and Listing (eDRLS) Using CDER Direct - 2024
OTC Monograph Reform: OMOR Format and Content & Electronic Submissions
Registrants that failed to provide annual amount reporting for calendar year 2024 are included on one of two lists on this page.
This material is intended to be a helpful resource that consolidates information relevant for drug manufacturers making products for the U.S. market. It is not a comprehensive list of all applicable statutory and regulatory requirements.
Introduction Blunt chest trauma is frequently associated with rib fractures, and inadequate pain control may lead to respiratory complications and prolonged ventilatory support. In spontaneously breathing patients, pain impairs coughing and secretion clearance, promoting atelectasis and respiratory failure, while in mechanically ventilated patients, it may delay weaning. Current French guidelines recommend intravenous multimodal analgesia as first-line therapy followed by thoracic epidural or paravertebral block if pain remains uncontrolled. However, these techniques have limited applicability…